WAC 246-240-281. Training for ophthalmic use of strontium-90

Except as provided in WAC 246-240-078 , the licensee shall require the authorized user of strontium-90 for ophthalmic radiotherapy to be a physician who: (1) Is an authorized user under WAC 246-240-278 or equivalent agreement state or NRC requirements; or (2)(a) Has completed 24 hours of classroom and laboratory training applicable to the medical use of strontium-90 for ophthalmic radiotherapy. The training must include: (i) Radiation physics and instrumentation; (ii) Radiation protection; (iii) Mathematics pertaining to the use and measurement of radioactivity; and (iv) Radiation biology; and (b) Supervised clinical training in ophthalmic radiotherapy under the supervision of an authorized user at a medical institution that includes the use of strontium-90 for the ophthalmic treatment of five individuals. This supervised clinical training must involve: (i) Examination of each individual to be treated; (ii) Calculation of the dose to be administered; (iii) Administration of the dose; and (iv) Follow up and review of each individual's case history; and (c) Has obtained written attestation, signed by a preceptor authorized user who meets the requirements in WAC 246-240-078 , 246-240-278 , 246-240-281, or equivalent agreement state or NRC requirements, that the individual has satisfactorily completed the requirements in (a) and (b) of this subsection and is able to independently fulfill the radiation safety-related duties as an authorized user of strontium-90 for ophthalmic use.